Join collection
Hello, welcome to our official website!
Innovation and imitation,opportunity and challenge
2019-08-20

filename

Asia-Pacific Pharma IP Leader summit2019---14th-15th NOV, Beijing CHINA

On March 19, 2019, the World Intellectual Property Organization (WIPO) published its global intellectual property report 2018.Asian innovators filed more than half of their international patent applications through WIPO for the first time in 2018, with significant growth in China, India and South Korea, the report noted. As a technology-intensive industry, pharmaceutical industry attaches great importance to patent application and intellectual property protection.

In recent years, the size of the global pharmaceutical market has maintained a steady growth, with China, South Korea, India and other emerging markets presenting a rapid growth momentum. Due to the different intellectual property policies of different countries, the strategic layout of global intellectual property, the differences of pharmaceutical intellectual property policies of Asia-pacific countries, the patent review process, litigation procedures and Generic drug patent strategy have gradually become the hot spots of the pharmaceutical intellectual property industry.

In this context, the 2019 Asia-pacific Pharmaceutical IP Leader Summit will be held in Beijing on November 14-15, and will attract more than 500 industry experts from domestic and foreign pharmaceutical companies, biotechnology companies, governments, associations, law firms, intellectual property agents and other companies to attend.

Agenda Framework:

Section 1Interpretation of Policy: Development of Pharmaceutical IP under the New Legislative Landscape

Section 2Pharmaceutical R&D Innovation and IP Protection -- Global Vision

Section 3Case Sharing of Pharmaceutical Patent Invalidity, Infringement, Litigation

Section 4Opportunities and challenges for generics companies under the new situation 

HOTSPOT:

ü  Medical Policy Interpretation under the Background of Patent Law Amendment

ü  The innovation of Judicial Mechanism Promotes the Development of Pharmaceutical Intellectual Property

ü  Intellectual Property Management Experience in Multinational Pharmaceutical Companies, Patent Layout Strategy, Litigation Strategy

ü  he Data Protection Regulations of Drug TestNew Era

ü  Trade Secrets and Patent Layout in the Medical Field

ü  Establishing The Internal Intellectual Property System under The New Legislative Landscape

ü  Opportunities and Challenges of Pharmaceutical Enterprises under Patent Term Compensation System--- Global Vision and Its Implications for China

ü  Latest Changes in European Patent Application and Review Procedures

ü  Analysis of Hot Cases of Recent Patent Invalidation

ü  The Procedure of American Pharmaceutical Patent litigation and its Enlightenment to Chinese Pharmaceutical Enterprises  

ü  Application techniques and protection strategies for European and American biomedical patents

ü  Changes in standards for creative review of patents

ü  European, American and Japanese Medical Patent Examination Cases and its implications for DomesticPharmaceutical Companies

ü  Recent Hot Patent Infringement Cases Analysis

ü  The Strategy of Indian Generic Drug Companies in R&D and Pre-PA

ü  How to avoid the Patent Trap in Generic Drug Development

ü  The Strategy of Generic Drug Companies to Enter the European and American Markets

ü  Patentability in Europe, the United States and China

ü  Patent litigation in Europe

ü  Doubts around the Unified Patent Court (UPC) agreement and Brexit

ü  Second medical use patents

Composition of participants

filename

 

 


Summit highlights


10+ Hot topic

20+   Authoritative speech

5 0+ Industry media

4 0+ BIC

110+pharma   company

500+专业参会嘉宾

                  Professional participants









Official registration and consultation channels:

ContactAnn

Phone: 021-65650305

EmailMarketing@zenseegroup.com

http://en.zenseegroup.com/p/510934/

暂无评论!
我要评论 只有购买过该商品的用户才能评论。

From :businessinsuranceU.S. commercial property/casualty rates rose 5% on average in the fourth quarter of 2019, up from 4% in the third quarter, reflecting insurers’ intent to continue to increase prices across most lines, online insurance exchange MarketScout Corp. said Monday.“Auto rate increases have been up all year long; however D&O (directors & officers) and professional rate increases have spiked significantly in the fourth quarter,” Richard Kerr, CEO of MarketScout Corp. said in a statement.Insurers are carefully analyzing their property exposures using catastrophe modeling tools, he said. “We expect many of the major property catastrophe insurers to curtail their 2020 writings in California brush and East and Gulf Coast wind areas. Naturally, this will result in higher rates to insureds,” Mr. Kerr said.D&O liability rates increased by 8.25%, while commercial auto increased 8% in the quarter, and professional liability rates were up 6%, and umbrella/excess rates were up 5.5%, according to MarketScout.Commercial property rates increased 5.25% in the quarter, and business interruption rates were up 5%, while all other lines showed smaller increases, except for workers compensation, where rates fell 1%, MarketScout said.By industry class, transportation and habitational saw the highest average rate increases at 9% and 8.25% respectively, MarketScout said.Large accounts – those with $250,001 to $1 million in premium – saw a rate hike of 5.5% in the fourth quarter, as did jumbo accounts, which have more than $1 million in premium. Small accounts – those with up to $25,000 in premium – were up 5%, while medium accounts – those with $25,001 to $250,000 in premium – were up 4.5%.The “steady trend” of upward rates reflects insurers’ plans to continue increasing prices across all lines except for workers compensation, MarketScout said.Organizer:China Insurance Digital & AI Development 2020Web:http://en.zenseegroup.com/p/560573/Contact:Ann 021-65650305

From :insurancejournalIt was a relatively quiet year for the Southeast in terms of major catastrophes compared with 2018 when Hurricane’s Michael and Florence caused major damage in the region. This year, Hurricane Dorian sideswiped the Southeast coast and made landfall on the Outer Banks of North Carolina but most of the area was spared. Still, Aon said economic damage in the U.S. and Canada was poised to approach a combined $1.5 billion.Florida spent the year recovering from Hurricane Michael, which was upgraded to a Category 5 storm by NOAA in April. Florida officials have repeatedly called on the insurance industry to speed up the recovery process, with nearly 12% of claims still open a year after the storm hit.Organizer:China Insurance Digital & AI Development 2020Web:http://en.zenseegroup.com/p/560573/Contact:Ann 021-65650305

From:businessinsuranceeinsurance renewals at Jan. 1, 2020, mainly saw single-digit increases, with some exceptions, according to reports by reinsurance brokers released Thursday.Willis Re, the reinsurance brokerage of Willis Towers Watson PLC, and Guy Carpenter & Co. LLC, a unit of Marsh & McLennan Cos. Inc. both reported that year-end reinsurance renewals varied by account and region, but the retrocessional reinsurance was under pressure.Rates on line for property catastrophe reinsurance programs remained stable and pro